While dasatinib had previously been shown to interfere with the phosphorylation of Akt (Thr308 and Ser473) in squamous cell lung cancer [22], we only detected inhibition of phosphorylation of Akt (Thr308). The gene discussed is AKT1; the disease is squamous cell lung carcinoma.